Top Headlines

Business

Innventure, Inc. Announces Closing of $40 Million Registered Direct Offering of Common Stock

With the proceeds from the offering, Innventure expects to fully repay all outstanding convertible d...

Globenewswire_fr 20 hours ago

Lifestyle

New Site in Lommel, Belgium: Aqua Free Successfully Completes Set-up Phase With Iso 9001 Certification

Aqua free has successfully moved into its new, state-of-the-art facility in Lommel and and has now a...

Globenewswire_fr 20 hours ago

Business

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

FY26 Q2 Earnings Release...

Globenewswire_fr 20 hours ago

Business

Homb Delivers Another Strong Quarter: $400 Million Loan Growth, Sub-40% Efficiency Ratio & Robust Margin Drive 18% Year-over-year Income Increase and Annual Roa of 2.10%

CONWAY, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB) (“Home” or th...

Globenewswire_fr 20 hours ago

Business

Ifi Network Appoints Veteran Vanguard Executive, James M. Delaplane, Jr., to Advisory Board

IFI Network Appoints Veteran Vanguard Executive, James M. Delaplane, Jr., to Advisory Board...

Globenewswire_fr 20 hours ago

Technology

Some Museum Entrance Fees Go Up for Non-eu Tourists in France

€10 more at the Louvre museum, €3 more at the Palace of Versailles... tourists visiting France f...

France 24 20 hours ago

Business

Daktronics to Present at Sidoti Small-cap Investor Conference

BROOKINGS, S.D., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Daktronics Inc. (Nasdaq: DAKT), a leading global ...

Globenewswire_fr 20 hours ago

Politics

Iran Protests: Ai and Dated Photos Mislead About Pro-regime Rallies

Amid nationwide protests in Iran against the country’s theocracy, this week has also seen rallies ...

France 24 20 hours ago

Business

Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results

CALGARY, Alberta, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerfl...

Globenewswire_fr 20 hours ago

Health

Ajovy® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents With Episodic Migraine Compared to Placebo in the Space Trial; Results Published in New England Journal of Medicine

PARSIPPANY, N.J. and TEL AVIV, Israel, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S...

Globenewswire_fr 20 hours ago